CDC42 and cardiac hypertrophy: Notably, the deletion of Cdc42 significantly decreased TAC- and AngII-induced cardiac hypertrophy and remodeling, as indicated by decreases in the LV mass, the HW/BW ratio and fibrosis in the hearts of Cdc42CKO mice.